Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Alanyl-Glutamine Added to Peritoneal Dialysis Solutions
2012-004004-36Phase 2Completed
- Sponsor
- Universitätsklinik für Kinder- und Jugendheilkunde
- Start
- Dec 2012
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of alanyl glutamine in end-stage kidney disease (ESKD) (2 arms), sponsored by Universitätsklinik für Kinder- und Jugendheilkunde. Primary endpoint: Cytokine release over time. Started Dec 2012; status: completed.
02
Drugs
alanyl glutamine
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2012-004004-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004004-36.